| 0.5099 0.51 (0%) | 04-20 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.6  |
1-year : | 0.7 |
| Resists | First : | 0.51 |
Second : | 0.6 |
| Pivot price | 0.39 |
|||
| Supports | First : | 0.29 |
Second : | 0.16 |
| MAs | MA(5) : | 0.44 |
MA(20) : | 0.38 |
| MA(100) : | 0.6  |
MA(250) : | 1.38 |
|
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 82.6 |
D(3) : | 72.2 |
| RSI | RSI(14): 60.9 |
|||
| 52-week | High : | 2.84 | Low : | 0.16 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ MGRX ] has closed above the upper band by 9.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 53.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 49 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.51 - 0.52 | 0.52 - 0.52 |
| Low: | 0.42 - 0.42 | 0.42 - 0.42 |
| Close: | 0.51 - 0.51 | 0.51 - 0.51 |
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
Fri, 17 Apr 2026
Mangoceuticals Inc. (MGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Fri, 17 Apr 2026
MGRX Stock Price, Quote & Chart | MANGOCEUTICALS INC (NASDAQ:MGRX) - ChartMill
Wed, 01 Apr 2026
Mangoceuticals 10-K: Revenue $0.456M, EPS loss $(2.17) - TradingView
Fri, 20 Mar 2026
Mangoceuticals (MGRX) CEO gets 2M options, bonus shares and trust note deal - Stock Titan
Fri, 20 Feb 2026
Here’s Why Mangoceuticals Stock (MGRX) Rocketed Today - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 0 (M) |
| Shares Float | 17 (M) |
| Held by Insiders | 1.169e+007 (%) |
| Held by Institutions | 10 (%) |
| Shares Short | 1,740 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.587e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 576.4 % |
| Return on Equity (ttm) | -70 % |
| Qtrly Rev. Growth | 456020 % |
| Gross Profit (p.s.) | -4.04 |
| Sales Per Share | -55.56 |
| EBITDA (p.s.) | 98192.1 |
| Qtrly Earnings Growth | -2.2 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 1.35 |
| Dividend | 0 |
| Forward Dividend | 1.02e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|